There were 2,198 press releases posted in the last 24 hours and 435,721 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
MRI Interventions’ ClearPoint® Neuro Navigation System to be Utilized in Medicenna Therapeutics’ Phase 2 MDNA55 Clinical Trial for the Treatment of Recurrent Glioblastoma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image